AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.415

-0.005-1.19%

Volume:23.85K

Turnover:10.15K

Market Cap:111.66M

PE:-18.35

High:0.430

Open:0.430

Low:0.415

Close:0.420

52wk High:0.630

52wk Low:0.120

Shares:269.05M

Float Shares:110.76M

Volume Ratio:0.05

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.023

EPS(LYR):-0.023

ROE:-90.37%

ROA:-49.16%

PB:15.60

PE(LYR):-18.35

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Island Pharmaceuticals Says US FDA Confirms Animal Model as Development Pathway for Antiviral Drug Candidate; Shares Rise 10%

MT Newswires Live

Island Pharmaceuticals to Raise AU$9 Million via Placement

MT Newswires Live

Island Pharmaceuticals Ltd - Placement of a$9 Mln at a$0.35 Each

THOMSON REUTERS

BRIEF-Island Pharmaceuticals Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ILA.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.415,"timestamp":1770694828321,"preClose":0.42,"halted":0,"volume":23847,"delay":0,"changeRate":-0.011904761904761916,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":269052397,"eps":-0.022614,"marketStatus":"Trading","change":-0.005,"latestTime":"02-10 14:51:44 AEDT","open":0.43,"high":0.43,"low":0.415,"amount":10150,"amplitude":0.035714,"askPrice":0.42,"askSize":17620,"bidPrice":0.415,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":-0.022614,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.42,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.047452,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-49.16%","roe":"-90.37%","lyrEps":-0.022614,"volumeRatio":0.047452,"shares":269052397,"dividePrice":0,"high":0.43,"amplitude":0.035714,"preClose":0.42,"low":0.415,"week52Low":0.12,"pbRate":"15.60","psRate":"939.00","week52High":0.63,"institutionHeld":0,"latestPrice":0.415,"committee":0.063264,"eps":-0.022614,"divideRate":0,"volume":23847,"delay":0,"ttmEps":-0.022614,"open":0.43,"prevYearClose":0.43,"prevWeekClose":0.42,"prevMonthClose":0.39,"prevQuarterClose":0.43,"fiveDayClose":0.39,"twentyDayClose":0.45,"sixtyDayClose":0.425,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608382642","title":"Island Pharmaceuticals Says US FDA Confirms Animal Model as Development Pathway for Antiviral Drug Candidate; Shares Rise 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608382642","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608382642?lang=en_us&edition=fundamental","pubTime":"2026-02-04 08:49","pubTimestamp":1770166184,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said the US Food and Drug Administration confirmed its proposed animal model as the development pathway for its antiviral drug candidate, Galidesivir, according to a Wednesday filing with the Australian bourse.The US FDA confirmed the core elements of the proposed animal model, including the use of the Angola strain of Marburg, and outlined the final steps required to develop Galidesivir toward approval under the Animal Rule, the filing said.Under the two-stage clinical development pathway, the company will start targeted dose optimization and pharmacokinetic studies using the first manufactured batch of Galidesivir, the filing added.Shares of the company rose past 10% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2608389259","title":"Island Pharmaceuticals to Raise AU$9 Million via Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608389259","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608389259?lang=en_us&edition=fundamental","pubTime":"2026-02-04 07:18","pubTimestamp":1770160692,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  received firm commitments to raise AU$9 million via a placement of 25.7 million shares at an issue price of AU$0.35 per share, according to a Wednesday filing with the Australian bourse.The offer price represents a 17.9% discount to the stock's 15-day volume weighted average price, the filing said.The new shares are expected to settle on Feb.13, the filing added.Funds raised will be used to advance the company's antiviral drug Galidesivir to approval under the US Food & Drug Administration's  Animal Rule.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2608038615","title":"Island Pharmaceuticals Ltd - Placement of a$9 Mln at a$0.35 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2608038615","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608038615?lang=en_us&edition=fundamental","pubTime":"2026-02-04 06:34","pubTimestamp":1770158093,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ1A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2608588466","title":"BRIEF-Island Pharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2608588466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608588466?lang=en_us&edition=fundamental","pubTime":"2026-02-02 05:44","pubTimestamp":1769982261,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Seeks Trading HaltFeb 2 (Reuters) - Island Pharmaceuticals ILA.AX:SEEKS TRADING HALT PENDING FDA FEEDBACK ON GALIDESIVIR PROGRAMFurther company coverage: ILA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nFWN3YV1SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ILA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}